Literature DB >> 23416669

Myeloid-cell differentiation redefined in cancer.

Thomas A Wynn.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23416669      PMCID： PMC3806344          DOI： 10.1038/ni.2539

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

Review 1.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 2.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

3.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

Review 4.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

Authors:  Kiavash Movahedi; Martin Guilliams; Jan Van den Bossche; Rafael Van den Bergh; Conny Gysemans; Alain Beschin; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Blood       Date:  2008-02-13       Impact factor: 22.113

Review 7.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.

Authors:  Patrick Viatour; Tim C Somervaille; Shivkumar Venkatasubrahmanyam; Scott Kogan; Margaret E McLaughlin; Irving L Weissman; Atul J Butte; Emmanuelle Passegué; Julien Sage
Journal:  Cell Stem Cell       Date:  2008-10-09       Impact factor: 24.633

9.  Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.

Authors:  Carl R Walkley; Jeremy M Shea; Natalie A Sims; Louise E Purton; Stuart H Orkin
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

10.  Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

Authors:  Je-In Youn; Vinit Kumar; Michelle Collazo; Yulia Nefedova; Thomas Condamine; Pingyan Cheng; Alejandro Villagra; Scott Antonia; Judith C McCaffrey; Mayer Fishman; Amod Sarnaik; Pedro Horna; Eduardo Sotomayor; Dmitry I Gabrilovich
Journal:  Nat Immunol       Date:  2013-01-27       Impact factor: 25.606
View more
  10 in total

1.  Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.

Authors:  Yi Ban; Junhua Mai; Xin Li; Marisa Mitchell-Flack; Tuo Zhang; Lixing Zhang; Lotfi Chouchane; Mauro Ferrari; Haifa Shen; Xiaojing Ma
Journal:  Cancer Res       Date:  2017-04-17       Impact factor: 12.701

2.  Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.

Authors:  Ha-Ram Cha; Joo Hyoung Lee; Jonathan A Hensel; Anandi B Sawant; Brittney H Davis; Carnellia M Lee; Jessy S Deshane; Selvarangan Ponnazhagan
Journal:  Prostate       Date:  2016-02-09       Impact factor: 4.104

3.  Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.

Authors:  Seth Levy; Joseph M Feduska; Anandi Sawant; Shawn R Gilbert; Jonathan A Hensel; Selvarangan Ponnazhagan
Journal:  Bone       Date:  2016-09-21       Impact factor: 4.398

4.  The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.

Authors:  Y Takeda; T Kato; H Ito; Y Kurota; A Yamagishi; T Sakurai; A Araki; H Nara; N Tsuchiya; H Asao
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

5.  6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.

Authors:  Laura Jeanbart; Iraklis C Kourtis; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Cancer Immunol Immunother       Date:  2015-05-16       Impact factor: 6.968

6.  Association of Chemokines and Chemokine Receptor Expression with Monocytic-Myeloid-Derived Suppressor Cells during Tumor Progression.

Authors:  Eun-Hye Seo; Ji Hyeon Namgung; Chung-Sik Oh; Seong-Hyop Kim; Seung Hyun Lee
Journal:  Immune Netw       Date:  2018-06-25       Impact factor: 6.303

Review 7.  Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.

Authors:  Nobuo Kondoh; Masako Mizuno-Kamiya; Eiji Takayama; Harumi Kawati; Naoki Umemura; Yutaka Yamazaki; Kenji Mitsudo; Iwai Tohnai
Journal:  Open Dent J       Date:  2018-06-20

8.  Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars.

Authors:  Yang Liu; Wei Huang; Chuanfeng Xiong; Yuxian Huang; Benny J Chen; Luigi Racioppi; Nelson Chao; Tuan Vo-Dinh
Journal:  Int J Nanomedicine       Date:  2019-05-09

Review 9.  The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis.

Authors:  Lan Yan; Mingge Liang; Tong Yang; Jinyu Ji; Goutham Sanker Jose Kumar Sreena; Xiaoqiang Hou; Meiqun Cao; Zhitao Feng
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

Review 10.  Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity.

Authors:  Pu Sun; Ling-Hua Meng
Journal:  Acta Pharmacol Sin       Date:  2020-09-16       Impact factor: 7.169
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.